What is Vizamyl, and what does “Vizamyl PubMed 2025” usually mean?
Vizamyl is a brand name for florbetaben F 18, a radiopharmaceutical used in PET imaging to help assess brain amyloid-β (Aβ) pathology. People searching “Vizamyl PubMed 2025” typically want PubMed articles published in 2025 about florbetaben/Vizamyl, such as clinical studies, imaging interpretation papers, or guideline/real-world use reports.
Which PubMed search terms work best for Vizamyl (florbetaben F 18)?
On PubMed, searches are usually more reliable with the chemical name and key synonyms, not just the brand name. Common terms include:
- “florbetaben”
- “florbetaben F 18”
- “Vizamyl”
- “amyloid PET”
- “amyloid-beta”
- “Alzheimer” (often paired with amyloid PET)
If you want results specifically from 2025, you can add the publication year filter (or include 2025[dp]).
How to find the 2025 PubMed results (quick workflow)
- Go to PubMed.
- Search for: florbetaben OR Vizamyl
- Use the filter for Publication dates → 2025.
If you tell me what you want (e.g., “clinical trial,” “diagnostic accuracy,” “pediatric,” “real-world,” “comparisons”), I can suggest tighter PubMed query strings.
What kinds of 2025 papers are commonly published for florbetaben/Vizamyl?
PubMed entries in this area often fall into:
- diagnostic performance/reader studies for amyloid PET tracers
- performance in different clinical populations (including at-risk groups)
- work on quantification approaches and scan interpretation workflows
- comparisons across amyloid tracers (depending on what was studied)
- guideline or practice-focused publications
Do you need Vizamyl specifically, or any amyloid PET tracer?
If your goal is amyloid PET evidence (not only Vizamyl), some 2025 studies may use other tracers (for example, other F-18 labeled agents or AV-45-related tracers). Searches limited to “Vizamyl” can miss important comparisons.
If you paste your PubMed results, I can summarize them
If you share the PubMed links or titles you’re seeing for “Vizamyl 2025,” I can:
- identify which are actually about florbetaben F 18
- summarize each paper’s main findings and design
- flag outcome measures (SUVR/cutoffs, sensitivity/specificity, etc.)
- pull out the most relevant results for your use case (clinical vs research vs regulatory)
Sources
No PubMed page content or specific 2025 citations were provided in your message, so I can’t list exact PubMed articles yet. If you send the search results (or the PubMed URLs), I’ll cite and summarize them precisely.